Gudan Wan reduced liver injury in mouse model of MASH
A preclinical mouse study found that Gudan Wan reduced liver injury, inflammation and fibrosis while altering autophagy- and apoptosis-related proteins, ...
A preclinical mouse study found that Gudan Wan reduced liver injury, inflammation and fibrosis while altering autophagy- and apoptosis-related proteins, ...
A 2026 narrative review proposes that MASH in type 2 diabetes often begins with dysfunctional adipose tissue, which disrupts lipid ...
A review finds that microbial metabolites may influence variable responses to MASH therapies, but direct clinical evidence linking gut microbial ...
A new review explains how gut microbes, host genetics and metabolic dysfunction interact to drive MASLD and shape emerging therapies.
A new review proposes that lipid metabolism plays fundamentally different roles at each stage of fatty liver disease progression to ...
A Duke-NUS pre-clinical study has created the first diet-induced mouse model of lean MASH, showing that excess dietary salt can ...
A phase-2 randomized trial shows intermittent dasatinib plus quercetin significantly improved liver fibrosis and resolved MASH in nearly half of ...
A comprehensive new review details how the bile acid receptors FXR and TGR5 regulate fat metabolism, inflammation, fibrosis, and liver ...
A first-in-human study shows the PDGFRβ-targeting PET tracer Ga-ATH001 delivers a safe radiation dose and highlights active liver fibrosis in ...
A new review charts how bile acids have evolved from simple digestive surfactants into a versatile platform for receptor agonists, ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine